Post-Marketing Surveillance of Fycompa Film-coated Tablets 2/4/6/8/10/12mg in Korean Patients
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Generalised seizures
- Focus Adverse reactions
- Sponsors Eisai Korea
- 27 Sep 2016 Status changed from not yet recruiting to recruiting.
- 18 Jul 2016 Planned End Date changed from 1 Jan 2021 to 1 Jun 2021.
- 18 Jul 2016 Planned primary completion date changed from 1 Jan 2021 to 1 Jun 2021.